BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18040780)

  • 21. HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta.
    Peng H; Erdmann N; Whitney N; Dou H; Gorantla S; Gendelman HE; Ghorpade A; Zheng J
    Glia; 2006 Nov; 54(6):619-29. PubMed ID: 16944452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Virology on AIDS and AIDS dementia complex].
    Hoshino H
    No To Shinkei; 1997 Jan; 49(1):39-49. PubMed ID: 9027901
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV infection and dementia.
    Gartner S
    Science; 2000 Jan; 287(5453):602-4. PubMed ID: 10691542
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.
    Eugenin EA; Gamss R; Buckner C; Buono D; Klein RS; Schoenbaum EE; Calderon TM; Berman JW
    J Leukoc Biol; 2006 Mar; 79(3):444-52. PubMed ID: 16507710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine receptors and neurotrophic factors: potential therapy against aids dementia?
    Mocchetti I; Bachis A; Masliah E
    J Neurosci Res; 2008 Feb; 86(2):243-55. PubMed ID: 17847079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.
    Bell JE; Arango JC; Anthony IC
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):182-91. PubMed ID: 18040783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine receptors in the human brain and their relationship to HIV infection.
    Lavi E; Kolson DL; Ulrich AM; Fu L; González-Scarano F
    J Neurovirol; 1998 Jun; 4(3):301-11. PubMed ID: 9639073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of HIV-1 associated neurodegeneration.
    Ozdener H
    J Biosci; 2005 Jun; 30(3):391-405. PubMed ID: 16052077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus.
    Shieh TM; Carter DL; Blosser RL; Mankowski JL; Zink MC; Clements JE
    J Neurovirol; 2001 Feb; 7(1):11-24. PubMed ID: 11519478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex.
    Nottet HS; Gendelman HE
    Immunol Today; 1995 Sep; 16(9):441-8. PubMed ID: 7546209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence.
    Maingat FG; Polyak MJ; Paul AM; Vivithanaporn P; Noorbakhsh F; Ahboucha S; Baker GB; Pearson K; Power C
    FASEB J; 2013 Feb; 27(2):725-37. PubMed ID: 23150523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.
    Hauser KF; El-Hage N; Stiene-Martin A; Maragos WF; Nath A; Persidsky Y; Volsky DJ; Knapp PE
    J Neurochem; 2007 Feb; 100(3):567-86. PubMed ID: 17173547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathogenesis of chimeric simian human immunodeficiency virus infection in rhesus macaques.
    Buch S; Pinson D; Hou Y; Adany I; Li Z; Mukherjee S; Jia F; Mackay G; Silverstein P; Kumar A; Narayan O
    J Med Primatol; 2000 Aug; 29(3-4):96-106. PubMed ID: 11085571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS.
    Langford D; Masliah E
    Brain Pathol; 2001 Jul; 11(3):306-12. PubMed ID: 11414473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is repetitive opportunistic infection in AIDS patients the effective mechanism for neurodegeneration in terms of endlessly amplifying cytokine/chemokine effect?
    Agius LM
    Med Hypotheses; 2004; 62(4):587-92. PubMed ID: 15050112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of human immunodeficiency virus in the central nervous system.
    Kolson DL; Lavi E; González-Scarano F
    Adv Virus Res; 1998; 50():1-47. PubMed ID: 9520995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuropathogenesis of HIV-1 infection.
    Zink WE; Zheng J; Persidsky Y; Poluektova L; Gendelman HE
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):233-41. PubMed ID: 10575134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of neuronal damage in AIDS].
    Nagashima K
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):37-41. PubMed ID: 9086361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.